Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application

Volume: 45, Issue: 1, Pages: 80 - 82
Published: Aug 31, 2015
Abstract
Takayasu arteritis (TAK) is a systemic vasculitis affecting the large arteries (1). Glucocorticoids and immunosuppressants including biological agents targeting tumour necrosis factor (TNF)-α and...
Paper Details
Title
Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application
Published Date
Aug 31, 2015
Volume
45
Issue
1
Pages
80 - 82
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.